Amphastar Pharmaceuticals Inc. (AMPH)
NASDAQ · Healthcare
Amphastar Pharmaceuticals Inc. Operating Income 2012–2025
Amphastar Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2012 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Amphastar Pharmaceuticals Inc. operating income for the quarter ending March 31, 2026 was 13.6 M, a 63.45% decrease year-over-year.
- Amphastar Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2026 was 118.4 M, a 49.16% decrease year-over-year.
- Amphastar Pharmaceuticals Inc. annual operating income for 2025 was 140.4 M, a 31.65% decrease from 2024.
- Amphastar Pharmaceuticals Inc. annual operating income for 2024 was 205.4 M, a 4.28% increase from 2023.
- Amphastar Pharmaceuticals Inc. annual operating income for 2023 was 197.0 M, a 83.25% increase from 2022.
- Amphastar Pharmaceuticals Inc. annual operating income for 2022 was 107.5 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Amphastar Pharmaceuticals Inc. Operating Income — FAQ
Amphastar Pharmaceuticals Inc. (AMPH) operating income over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
What is Amphastar Pharmaceuticals Inc.'s operating income?
Amphastar Pharmaceuticals Inc. (AMPH) reported operating income of $140M for fiscal 2025.
Where can I see AMPH's operating income history?
The chart and table above show Amphastar Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.